Related Experiment Videos

Hyperammonaemia without portal systemic shunting does not resemble hepatic encephalopathy

R A Chamuleau¹, B A Vogels

¹Laboratory of Experimental Internal Medicine, University of Amsterdam, The Netherlands.

Advances in Experimental Medicine and Biology

|January 1, 1997

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effect and side-effects of alpha interferon treatment in haemophilia patients with chronic hepatitis C.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Extrahepatic portal vein thrombosis: aetiology and determinants of survival.

Gut·2001

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration.

The Journal of biological chemistry·2001

Sustained virological response in chronic hepatitis C patients after a 6- and a 36-month interferon-alpha2b treatment schedule: a multicenter, randomized, controlled study.

Scandinavian journal of gastroenterology·2001

Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.

Blood·2000

A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals.

Journal of clinical pathology·2000

See all related articles